Serendipitous Discovery Sheds Light on Chronic Fatigue Syndrome


Like many health conditions that do not present in obvious ways to the current diagnostic technology of Western medicine, chronic fatigue syndrome (CFS) has been a marginalized.  It is often seen as psychogenic or “not having a medical cause”.

Traditional health practitioners often focus on enhancing digestion and resorting general health of people with CFS symptoms.  It can be hard to determine what is the root cause of a person’s problems if their digestion is weak and their diet and lifestyle are not optimal.

Rituximab, a drug which effects cells the make antibodies, was used to treat lymphoma and rheumatoid arthritis.  But it was also noticed to benefit CFS symptoms. In a recently published study researchers from Norway put this drug to the test for CFS and found it helped participants significantly.

From the findings of the study:

Major or moderate responses, predefined as lasting improvements in self-reported Fatigue score, were detected in 18 out of 29 patients (intention to treat). Clinically significant responses were seen in 18 out of 28 patients (64%) receiving rituximab maintenance treatment. For these 18 patients, the mean response durations within the 156 weeks study period were 105 weeks in 14 major responders, and 69 weeks in four moderate responders. At end of follow-up (36 months), 11 out of 18 responding patients were still in ongoing clinical remission.

“Chronic Fatigue Syndrome usually responds, slowly, to continued use of Restorative Herbs backed up by short bursts of Immune System stimulants, plus lots of loving attention.” — Christopher Hedley

Comment on the forum